606 related articles for article (PubMed ID: 33271067)
21. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 538():97-103. PubMed ID: 33602511
[TBL] [Abstract][Full Text] [Related]
23. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
[TBL] [Abstract][Full Text] [Related]
24. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
Asarnow D; Wang B; Lee WH; Hu Y; Huang CW; Faust B; Ng PML; Ngoh EZX; Bohn M; Bulkley D; Pizzorno A; Ary B; Tan HC; Lee CY; Minhat RA; Terrier O; Soh MK; Teo FJ; Yeap YYC; Seah SGK; Chan CEZ; Connelly E; Young NJ; Maurer-Stroh S; Renia L; Hanson BJ; Rosa-Calatrava M; Manglik A; Cheng Y; Craik CS; Wang CI
Cell; 2021 Jun; 184(12):3192-3204.e16. PubMed ID: 33974910
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
27. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
Zhu X; Mannar D; Srivastava SS; Berezuk AM; Demers JP; Saville JW; Leopold K; Li W; Dimitrov DS; Tuttle KS; Zhou S; Chittori S; Subramaniam S
PLoS Biol; 2021 Apr; 19(4):e3001237. PubMed ID: 33914735
[TBL] [Abstract][Full Text] [Related]
28. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
Xu C; Wang Y; Liu C; Zhang C; Han W; Hong X; Wang Y; Hong Q; Wang S; Zhao Q; Wang Y; Yang Y; Chen K; Zheng W; Kong L; Wang F; Zuo Q; Huang Z; Cong Y
Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33277323
[TBL] [Abstract][Full Text] [Related]
29. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Huo J; Zhao Y; Ren J; Zhou D; Duyvesteyn HME; Ginn HM; Carrique L; Malinauskas T; Ruza RR; Shah PNM; Tan TK; Rijal P; Coombes N; Bewley KR; Tree JA; Radecke J; Paterson NG; Supasa P; Mongkolsapaya J; Screaton GR; Carroll M; Townsend A; Fry EE; Owens RJ; Stuart DI
Cell Host Microbe; 2020 Sep; 28(3):445-454.e6. PubMed ID: 32585135
[TBL] [Abstract][Full Text] [Related]
30. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody.
Yin W; Xu Y; Xu P; Cao X; Wu C; Gu C; He X; Wang X; Huang S; Yuan Q; Wu K; Hu W; Huang Z; Liu J; Wang Z; Jia F; Xia K; Liu P; Wang X; Song B; Zheng J; Jiang H; Cheng X; Jiang Y; Deng SJ; Xu HE
Science; 2022 Mar; 375(6584):1048-1053. PubMed ID: 35133176
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain.
Anzai I; Fujita J; Ono C; Kosaka Y; Miyamoto Y; Shichinohe S; Takada K; Torii S; Taguwa S; Suzuki K; Makino F; Kajita T; Inoue T; Namba K; Watanabe T; Matsuura Y
Microbiol Spectr; 2024 Apr; 12(4):e0365523. PubMed ID: 38415660
[TBL] [Abstract][Full Text] [Related]
32. Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction.
Ahmad J; Jiang J; Boyd LF; Zeher A; Huang R; Xia D; Natarajan K; Margulies DH
J Biol Chem; 2021 Oct; 297(4):101202. PubMed ID: 34537245
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2.
Ahn H; Calderon BM; Fan X; Gao Y; Horgan NL; Jiang N; Blohm DS; Hossain J; Rayyan NWK; Osman SH; Lin X; Currier M; Steel J; Wentworth DE; Zhou B; Liang B
J Med Virol; 2023 Oct; 95(10):e29163. PubMed ID: 37842796
[TBL] [Abstract][Full Text] [Related]
34. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
35. Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2.
Bracken CJ; Lim SA; Solomon P; Rettko NJ; Nguyen DP; Zha BS; Schaefer K; Byrnes JR; Zhou J; Lui I; Liu J; Pance K; ; Zhou XX; Leung KK; Wells JA
Nat Chem Biol; 2021 Jan; 17(1):113-121. PubMed ID: 33082574
[TBL] [Abstract][Full Text] [Related]
36. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.
Huang X; Zhang C; Pearce R; Omenn GS; Zhang Y
J Proteome Res; 2020 Dec; 19(12):4844-4856. PubMed ID: 33175551
[TBL] [Abstract][Full Text] [Related]
37. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
[TBL] [Abstract][Full Text] [Related]
38. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
Villoutreix BO; Calvez V; Marcelin AG; Khatib AM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580
[TBL] [Abstract][Full Text] [Related]
39. Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
Ngo VA; Jha RK
PLoS One; 2021; 16(9):e0257905. PubMed ID: 34582502
[TBL] [Abstract][Full Text] [Related]
40. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X
Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
